Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Novartis
Harvard Business School
Julphar
Johnson and Johnson
Cantor Fitzgerald
Federal Trade Commission
Deloitte
US Army

Generated: February 25, 2018

DrugPatentWatch Database Preview

Propafenone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for propafenone hydrochloride and what is the scope of propafenone hydrochloride patent protection?

Propafenone hydrochloride
is the generic ingredient in three branded drugs marketed by Glenmark Pharms Ltd, Mylan Pharms Inc, Par Pharm, Watson Labs Inc, Glaxosmithkline Llc, Ani Pharms Inc, Aurobindo Pharma Ltd, Nesher Pharms, Sun Pharm Industries, Vintage Pharms, and Watson Labs, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for propafenone hydrochloride. Nineteen suppliers are listed for this compound.
Pharmacology for propafenone hydrochloride
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for propafenone hydrochloride

US Patents and Regulatory Information for propafenone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 202688-002 Aug 24, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078540-002 Oct 18, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nesher Pharms PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076193-003 Feb 7, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076550-003 Apr 23, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc RYTHMOL propafenone hydrochloride TABLET;ORAL 019151-001 Nov 27, 1989 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nesher Pharms PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076193-002 Feb 7, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075998-003 Nov 29, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc RYTHMOL propafenone hydrochloride TABLET;ORAL 019151-002 Nov 27, 1989 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075203-002 Oct 24, 2000 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076550-001 Apr 23, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for propafenone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-001 Sep 4, 2003 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-002 Sep 4, 2003 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-003 Sep 4, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Moodys
QuintilesIMS
Cantor Fitzgerald
AstraZeneca
Healthtrust
Accenture
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot